These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32397452)

  • 1. The Characteristics of Care Provided to Population(s) in Precarious Situations in 2015. A Preliminary Study on the Universal Health Cover in France.
    Birault F; Mignot S; Caunes N; Boutin P; Bouquet E; Pérault-Pochat MC; Thirioux B
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32397452
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposure to High Precariousness Prevalence Negatively Impacts Drug Prescriptions of General Practitioners to Precarious and Non-Precarious Populations: A Retrospective Pharmaco-Epidemiological Study.
    Birault F; Le Bonheur L; Langbour N; Clodion S; Jaafari N; Perault-Pochat MC; Thirioux B
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difficulties in the management of precarious patients and precarious migrants].
    Flye Sainte Marie C; Querrioux I; Baumann C; Di Patrizio P
    Sante Publique; 2015; 27(5):679-90. PubMed ID: 26752034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.
    Verger P; Rolland S; Paraponaris A; Bouvenot J; Ventelou B
    Fundam Clin Pharmacol; 2010 Aug; 24(4):509-16. PubMed ID: 19840120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doctor-patient relationship in situations of economic precarity: the patient's point of view].
    Marron-Delabre A; Rivollier E; Bois C
    Sante Publique; 2015; 27(6):837-40. PubMed ID: 26916856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why underserved patients do not consult their general practitioner for depression: results of a qualitative and a quantitative survey at a free outpatient clinic in Paris, France.
    Rondet C; Parizot I; Cadwallader JS; Lebas J; Chauvin P
    BMC Fam Pract; 2015 May; 16():57. PubMed ID: 25951898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
    Pichetti S; Sermet C; Godman B; Campbell SM; Gustafsson LL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):205-18. PubMed ID: 23609765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeopathy in France in 2011-2012 according to reimbursements in the French national health insurance database (SNIIRAM).
    Piolot M; Fagot JP; Rivière S; Fagot-Campagna A; Debeugny G; Couzigou P; Alla F
    Fam Pract; 2015 Aug; 32(4):442-8. PubMed ID: 25921648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waiting for common-law solutions for the most vulnerable populations' healthcare access.
    Warin P
    Rev Epidemiol Sante Publique; 2019 Feb; 67 Suppl 1():S33-S40. PubMed ID: 30639052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback and lessons from the prescription of rimonabant, a drug to be used under strict guidelines, in southeastern France, March 2007 through June 2008.
    Jardin M; Cortaredona S; Bocquier A; Nauleau S; Sciortino V; Bouvenot J; Sauze L; Bouvenot G; Verger P
    Rev Epidemiol Sante Publique; 2011 Apr; 59(2):115-22. PubMed ID: 21435807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
    Riou França L; Vidal C; Bourechak N; Jeunne PL; Deville GS; Massol J
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):760-8. PubMed ID: 23208799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Migration, health and healthcare access].
    Larchanché S
    Soins; 2020; 65(843-844):16-19. PubMed ID: 32563500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous access to healthcare, a bond of trust with the patient].
    Mechali D; Dehaudt S; Pintir ML
    Rev Infirm; 2015 Oct; (214):23-4. PubMed ID: 26455620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical, psychological and social study in 350 patients in a precarious situation, undertaken by a permanently maintained health care facility in 2002].
    de la Blanchardière A; Méouchy G; Brunel P; Olivier P
    Rev Med Interne; 2004 Apr; 25(4):264-70. PubMed ID: 15050793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precariousness, Diabetes Control and Complications in French Guiana.
    Linière S; Nacher M; Drak Alsibai K; Mergeayfabre M; Hafsi N; Charpin A; Misslin-Tritsch C; Carod JF; Aurelus JM; De Toffol B; Ntoutoum A; Kakamba JB; Demar M; Helene-Pelage J; Adenis A; Sabbah N
    Front Endocrinol (Lausanne); 2022; 13():937156. PubMed ID: 35937802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The free delivery of drugs during hospital consultations].
    Haus R; Moutel G; Montuclard L; François I; Frebault M; Rozenbaum L; Bertrandon R; Hervé C
    Presse Med; 2003 Sep; 32(28):1303-9. PubMed ID: 14506437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obstacles to effective treatment of depression. A general practitioners' postal survey in the north-west region of France].
    Mercier A; Kerhuel N; Stalnikiewitz B; Aulanier S; Boulnois C; Becret F; Czernichow P
    Encephale; 2010 Jun; 36 Suppl 2():D73-82. PubMed ID: 20513464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.